India-ah hian vaccine chi li – Oxford-AstraZeneca, tual chhunga Covishield an tih; Indian firm Bharat Biotech-in an siam Covaxin; Russian siam Sputnik V leh Corbevax an hmang.
Covishield hi hman rim ber niin puitling vaccine la zinga 80% vel zetin an dawn a ni.
Corbevax hi protein-based vaccine an tih ang niin Biological E siam a ni a, India-a damdawi thuneitute chuan February, 2022 khan naupang kum 12 leh 18 inkarte hnena pek turin a pawm.
June thla khan Serum Institute of India-in an siam, Covovax chu a \ul chinah tak tak chauh naupang kum sarih leh 12 inkarte hman tura hman phalna pek a ni bawk.
Sorkar chuan Indian pharma company Cipla hnenah Moderna siam vaccine chawk luh phalna a pe bawk a, he damdawi hi Covid-19 laka 95% vela hna thawk thei nia sawi a ni a; mahse, tun thleng hi chuan India-ah hman tur a la awm rih lo.
February thla khan dose khat chauh lak ngai chi, Sputnik Light an tih, Sputnik V ang deuhva duan chu hman phalna pek a lo ni tawh bawk.